Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.94 |
| ▸ | CA2 | P00918 | 3/20 | 0.94 |
| ▸ | HTR6 | P50406 | 1/20 | 0.81 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.67 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.67 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.67 |
| ▸ | FABP4 | P15090 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | CASP1 | P29466 | 1/20 | 0.64 |
| ▸ | CASP7 | P55210 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.63 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.63 |
| ▸ | DRD1 | P21728 | 1/20 | 0.63 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL9518648 | 0.92 | CA1 (0.78) | CA1CA2HTR6HDAC1HDAC10 | |
| Phenylhydrazine SCHEMBL27728167 | 0.89 | CA1 (0.74) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL30480040 | 0.89 | CA1 (0.78) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL7464584 | 0.84 | CA1 (0.67) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL6038295 | 0.83 | CA1 (0.66) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL8038616 | 0.83 | CA1 (0.65) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL3857256 | 0.83 | CA1 (0.65) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL8038611 | 0.82 | CHRM2 (0.85) | CA1CA2HTR6HDAC1HDAC10 | |
| SCHEMBL12938861 | 0.81 | HDAC6 (1.00) | CA1CA2HDAC1HDAC10HDAC6 | |
| SCHEMBL1367032 | 0.80 | HDAC6 (0.98) | CA1CA2HDAC1HDAC10HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8486990-B2 | SirT inhibitors that bind to NAD | ELIXIR PHARMACEUTICALS, INC. (US) | 2013-07-16 | — | — | US | disclosed |
| US-20060074124-A1 | Methods of treating a disorder | IPSOL AG (LI) | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074124-A1 | Methods of treating a disorder | CPT1B, CYP27A1, CLN6 | CA1 2767/4885CA2 4062/4885HTR6 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.